Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas

被引:47
作者
Wu, TC
Lin, P
Hsu, CP
Huang, YJ
Chen, CY
Chung, WC
Lee, H
Ko, JL
机构
[1] Chung Shan Med Univ, Inst Toxicol, Taichung 40203, Taiwan
[2] Chung Shan Med Univ Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan
[3] Taichung Vet Gen Hosp, Dept Thorac Surg, Taichung, Taiwan
[4] Taichung Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taichung, Taiwan
关键词
telomerase; TRAP; lung cancer;
D O I
10.1016/S0169-5002(03)00195-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many cancer and immortal cells exhibit telomerase activity that stabilizes telomere lengths, possibly contributing to cell immortality and carcinogenesis. The aim of this study was to elucidate the clinicopathological relationship between telomerase activity and telomerase reverse transcriptase subunit (hTERT) status in non small cell lung cancer. hTERT status in non small cell lung cancer using telomeric repeat amplification protocol (TRAP) and RT-PCR assay, respectively. Telomerase activity and hTERT were detected in 85.7 and 80.3% of cancerous tissues, respectively. Telomerase activity does not correlate with clinicopathological variables. However, there was an association between p53-corretated expression and hTERT negative status. Lung cancer patients without telomerase activity survived for a significantly longer period than those with telomerase activity. In addition, hTERT was not associated with the prognosis. TERT expression did not correlate well with any clinical parameter. Reactivated telomerase activity may be a poor prognostic factor in NSCLCs. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 19 条
[1]   Expression of human telomerase subunit genes in primary lung cancer and its clinical significance [J].
Arinaga, M ;
Shimizu, S ;
Gotoh, K ;
Haruki, N ;
Takahashi, T ;
Takahashi, T ;
Mitsudomi, T .
ANNALS OF THORACIC SURGERY, 2000, 70 (02) :401-405
[2]  
Devereux TR, 1999, CANCER RES, V59, P6087
[3]   Human keratinocytes that express hTERT and also bypass a p16INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics [J].
Dickson, MA ;
Hahn, WC ;
Ino, Y ;
Ronfard, V ;
Wu, JY ;
Weinberg, RA ;
Louis, DN ;
Li, FP ;
Rheinwald, JG .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (04) :1436-1447
[4]   Increased sensitivity and reproducibility of TRAP assay by avoiding direct primers interaction [J].
Falchetti, ML ;
Levi, A ;
Molinari, P ;
Verna, R ;
D'Ambrosio, E .
NUCLEIC ACIDS RESEARCH, 1998, 26 (03) :862-863
[5]   Quantitative analysis of telomerase activity and telomerase reverse transcriptase expression in renal cell carcinoma [J].
Hara, T ;
Noma, T ;
Yamashiro, Y ;
Naito, K ;
Nakazawa, A .
UROLOGICAL RESEARCH, 2001, 29 (01) :1-6
[6]   The illusion of cell immortality [J].
Hayflick, L .
BRITISH JOURNAL OF CANCER, 2000, 83 (07) :841-846
[7]   Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends [J].
Howe, HL ;
Wingo, PA ;
Thun, MJ ;
Ries, LAG ;
Rosenberg, HM ;
Feigal, EG ;
Edwards, BK .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (11) :824-842
[8]   Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit [J].
Kang, SS ;
Kwon, T ;
Kwon, DY ;
Do, SI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) :13085-13090
[9]   SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER [J].
KIM, NW ;
PIATYSZEK, MA ;
PROWSE, KR ;
HARLEY, CB ;
WEST, MD ;
HO, PLC ;
COVIELLO, GM ;
WRIGHT, WE ;
WEINRICH, SL ;
SHAY, JW .
SCIENCE, 1994, 266 (5193) :2011-2015
[10]   Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells [J].
Li, H ;
Zhao, LL ;
Funder, JW ;
Liu, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (27) :16729-16732